Company · CIK 1607245
Oasmia Pharmaceutical AB
| CIK | 1607245 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | V7 |
| Business address | Sweden |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2016-08-26 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-224536 | 2018-04-30 | 2019-08-12 | 3 | |
| 333-205515 | 2015-07-06 | 2017-08-07 | 14 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2019-08-12 | EFFECTDeclared effective | 333-224536 | 9999999995-19-001856 |
| 2018-05-24 | EFFECTDeclared effective | 333-224536 | 9999999995-18-001335 |
| 2018-04-30 | F-3Shelf registered | 333-224536 | 0001144204-18-023831 |
| 2017-08-07 | EFFECTDeclared effective | 333-205515 | 9999999995-17-002051 |
| 2016-08-02 | EFFECTDeclared effective | 333-205515 | 9999999995-16-005314 |
| 2015-10-27 | 424B4Final prospectus | 333-205515 | 0001144204-15-060967 |
| 2015-10-27 | 424B4Final prospectus | 333-205515 | 0001144204-15-060820 |
| 2015-10-22 | EFFECTDeclared effective | 333-205841 | 9999999995-15-002855 |
| 2015-10-22 | EFFECTDeclared effective | 333-205515 | 9999999995-15-002837 |
| 2015-10-22 | F-1/AAmendment | 333-205515 | 0001144204-15-060403 |
| 2015-10-21 | F-1/AAmendment | 333-205515 | 0001144204-15-060255 |
| 2015-10-19 | F-1/AAmendment | 333-205515 | 0001144204-15-059987 |
| 2015-10-09 | F-1/AAmendment | 333-205515 | 0001144204-15-058909 |
| 2015-09-25 | F-1/AAmendment | 333-205515 | 0001144204-15-056546 |
| 2015-09-16 | F-1/AAmendment | 333-205515 | 0001144204-15-055229 |
| 2015-09-04 | F-1/AAmendment | 333-205515 | 0001144204-15-053808 |
| 2015-08-14 | F-1/AAmendment | 333-205515 | 0001144204-15-049758 |
| 2015-07-06 | F-1Registration filed | 333-205515 | 0001144204-15-041182 |
| 2014-05-30 | DRSDraft made public | 377-00640 | 0000912057-14-000176 |